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Abstract: Infections of orthopedic implants are associated with high morbidity. The emergence of
antibiotic resistant strains and the tendency of microbes to form biofilms on orthopedic devices
prompt the individuation of novel antimicrobial agents. Silver nanoparticles represent an interesting
alternative, but their effects on bone cells need to be clarified. We focused on osteoblast-like cells and
on bone marrow-mesenchymal stem cells and found that these cells are rather resistant to the cytotoxic
effects of silver nanoparticles, with a half maximal inhibitory concentration around 25 µg/mL as
detected by MTT assay. Within a month of treatment, osteoblast-like cells adapt to the presence of
the nanoparticles by upregulating hsp70 as shown by western blot. Hsp70 overexpression correlates
with the restoration of normal cell proliferation. No alterations in the extent and time requirements
were detected in mesenchymal stem cell induced to differentiate in osteoblasts in the presence of
silver nanoparticles. Because the concentrations of silver nanoparticles which show antimicrobial
activity are lower than those exerting toxic effects on bone-forming cells in vitro, we suggest that
silver nanoparticles might represent a challenging tool to fight infections in orthopedic implants.
Keywords: silver nanoparticles; osteoblasts; mesenchymal stem cells
1. Introduction
Thanks to the remarkable development of bioengineering, orthopedic implants are widely used
to replace joints or to support damaged bones. Unfortunately, infections are relatively common
and represent a major source of morbidity [1,2]. In particular, bacteria tend to generate biofilms on
orthopedic devices and, once biofilms are formed, microbes resist immune attack and antibiotics [3].
This fact, in addition to the boost of antibiotic-resistant microorganisms, has triggered the development
of novel antimicrobial agents. Because of their antiseptic effects, attention has been focused on metals,
especially on metallic nanoparticles (NP), which are stable and provide a large surface area for
contact with bacteria. Recently, silver nanoparticles (Ag NP) have emerged for their potent antiseptic
properties [4] and are widely employed for domestic and medical devices. Ag NP show a marked
bactericidal activity against Gram-positive and -negative bacteria and are effective also against
antibiotic-resistant strains [4], because, after entering the bacteria, they inhibit enzymes and damage
DNA and bacterial cell membranes [4]. On these bases, orthopedic implants coated with Ag NP have
been developed and some of them are utilized in clinical trials [5].
However, concerns are raised about Ag NP biocompatibility. Ag NP cause abnormalities in
zebrafish development in a dose-dependent manner [6] and are toxic for a variety of normal
and neoplastic cells [7–11] mainly by generating oxidative and nitrosative stresses [9,10]. Since
nanoparticulate silver coatings for orthopedic implants represent a promising approach to prevent
infections, the effects of Ag NP have been studied on bone cells. Ag NP are toxic for osteoblasts [12–14],
specialized bone forming cells, and osteoclasts [12], which resorb the bone. In the case of osteoblasts,
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toxicity has been linked to the activation of inducible nitric oxide synthase (iNOS) with consequent
accumulation of nitric oxide and reactive nitrogen species, which have deleterious effects on human
osteoblast metabolism [14]. In addition, controversial results are available about mesenchymal stem
cells (MSC), the multipotent precursors of osteoblasts. Ag NP impair the viability of human MSC
(hMSC) in a dose- and time-dependent fashion, likely through the induction of DNA damage [15],
while they do not influence their differentiation [16]. Another study, however, shows that Ag NP, which
enter the cells through endocytosis and then accumulate in the cytosol, attenuate both osteogenic and
adipogenic differentiation of hMSC, even at non-toxic concentrations [17]. On the contrary, Ag NP
stimulate the osteogenic differentiation of murine MSC by activating TGF beta signaling [18].
It is very difficult to summarize data about the effects of Ag NP on cultured cells because the
experiments are performed with Ag NP of different size, used at different concentrations and for
different times. However, all the results available agree on the fact that Ag NP are toxic to many cell
types in a dose dependent manner.
In this study, we have investigated the behavior of Saos-2 osteoblast-like cells [19] exposed to
various concentrations of Ag NP for different times. These cells have been widely used to study
bone formation, osteoporosis and also for biomedical applications [20–22] since they show a mature
osteoblastic phenotype. Because Ag NP and hMSC are used in bone tissue engineering, we also studied
how hMSC [23] respond to Ag NP in terms of viability and osteogenic differentiation.
2. Results
2.1. Ag NP Reduce Viability and Increase ROS Production in Saos-2
We investigated the toxicity of Ag NP on Saos-2 by culturing them in the presence of different
concentrations of Ag NP for five days. By MTT assay, we found that Ag NP reduce the viability
of Saos-2 in a dose-dependent manner with a half maximal inhibitory concentration (IC50) around
25 µg/mL (Figure 1A). We then performed the Annexin V/PI staining and found that 10 and 25 µg/mL
Ag NP increases cell death after 24 h. In particular, a significant increase of late apoptotic phase was
detected with 25 µg/mL. After exposure to 10 and 25 µg/mL Ag NP, a marked increase of necrotic cells
was detected (Figure 1B). Since several studies link Ag NP toxicity with the accumulation of reactive
oxygen species (ROS), we quantified ROS levels after exposing Saos-2 to Ag NP for 24 h and detected
a significant dose-dependent increase of ROS starting from 10 µg/mL (Figure 1C). It is noteworthy,
however, that cytotoxicity occurs at lower concentrations, possibly induced by other mechanisms.
Similar results were obtained when we utilized PolyVinylPyrrolidone (PVP)-coated Ag NP
(not shown), as previously shown in another cell type [8], thus ruling out a role of Ag ions in
causing toxicity.
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Figure 1. Ag NP are cytotoxic for Saos-2. (A) Saos-2 were cultured for 5 days with Ag NP (0.5–100 
µg/mL). Viability was assessed by MTT assay. Data are expressed as the percentage of control (-). p 
value was calculated vs. untreated cells: * p < 0.05, ** p < 0.01, *** p < 0.001; (B) Saos-2 were treated for 
24 h with Ag NP (10 and 25 µg/mL). After staining with Annexin V/PI flow cytometry was performed. 
% of the cells in early, late apoptosis or necrosis were shown in the graphic. Data are the means ± 
standard deviation (SD) of three separate experiments. p value was calculated vs. untreated cells (-): 
* p < 0.05, ** p < 0.01; (C) After 24 h of culture in the presence of Ag NP, ROS production was measured. 
Results are shown as the fold increase of ROS in Ag NP treated cells vs. untreated control (-). Data are 
the means ± SD of three separate experiments in triplicate. p value was calculated vs. untreated cells: 
** p < 0.01, *** p < 0.001. 
2.2. Saos-2 Adapt to Long Term Exposure to Ag NP 
To evaluate the effects of long term exposure to Ag NP, we treated Saos-2 with three different 
concentrations of Ag NP (5, 10, and 25 µg/mL) for more than a month. All the cells were trypsinized 
and counted as soon as the control untreated cells reached confluence. Then, the cells were seeded 
again at the same density. As shown in Figure 2A, after seven days of treatment, cell growth was 
severely impaired at all the concentrations tested. The proliferation of Saos-2 exposed to 5 or 10 
µg/mL was restored to levels comparable with the untreated controls after 15 and 22 days, 
respectively, from the beginning of the experiment. Only after 35 days the toxic effect of 25 µg/mL of 
Ag NP was significantly reduced. We reasoned that, upon long term exposure to Ag NP, the cells 
become resistant to the toxic effects of Ag NP, possibly by activating a stress response. To test this 
issue, Saos-2 were treated for 15 and 22 days with Ag NP (10 and 25 µg/mL) and a western blot was 
performed on lysates using anti-hsp70 antibodies. Figure 2B shows a time- and dose-dependent 
upregulation of hsp70. 
We also investigated whether exposure to Ag NP caused DNA strand breaks in Saos-2 by comet 
assay. As demonstrated in Figure 2C, 1 and 2 days of Ag NP treatment induced genotoxic stress as 
shown by the formation of comets. Comet assay was also performed on Saos-2 treated 35 days with 
Ag NP. Figure 2C (right panel) shows that genotoxicity was completely reversible upon long term 
exposure to NP at the concentration of 10 µg/mL, whereas in Saos-2 exposed to 25 µg/mL of Ag NP 
genotoxicity was only partially reversible. 
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Figure 1. Ag NP are cytotoxic for Saos-2. (A) Saos-2 were cultured for 5 days with Ag NP
(0.5–100 µg/mL). Viability was assessed by MTT assay. Data are expressed as the percentage of
control (-). p value was calculated vs. untreated cells: * p < 0.05, ** p < 0.01, *** p < 0.001; (B) Saos-2 were
treated for 24 h with Ag NP (10 and 25 µg/mL). After staining with Annexin V/PI flow cytometry was
performed. % of the cells in early, late apoptosis or necrosis were shown in the graphic. Data are the
means ± standard deviation (SD) of three se arate experiments. p value was calculated vs. untreated
cells (-): * p < 0.05, ** p < 0.01; (C) After 24 h of culture in the presence of Ag NP, ROS production
was me sured. Results are shown as the fold increase of ROS in Ag NP tr t cells vs. untre ted
control (-). Data are th m ans ± SD of thr e separate exp riments in triplicate. p value was calculated
vs. untreated cells: ** p < 0.01, *** p < 0.001.
2.2. Saos-2 Adapt to Long Term Exposure to Ag NP
To evaluate the effects of long ter exposure to Ag NP, e treated Saos-2 ith three different
concentrations of Ag NP (5, 10, and 25 µg/ L) for ore than a onth. All the cells were trypsinized
and counted as soon as the control untreated cells reached confluence. Then, the cells were seeded again
at the same density. As shown in Figure 2A, after seven days of treatment, cell growth was severely
impaired at all the concentrations tested. The proliferation of Saos-2 exposed to 5 or 10 µg/mL was
restored to levels comparable with the untreated controls after 15 and 22 days, respectively, from the
beginning of the experiment. Only after 35 days the toxic effect of 25 µg/mL of Ag NP was significantly
reduced. We reasoned that, upon long term exposure to Ag NP, the cells become resistant to the toxic
effects of Ag NP, possibly by activating a stress response. To test this issue, Saos-2 were treated for
15 and 22 days with Ag NP (10 and 25 µg/mL) and a western blot was performed on lysates using
anti-hsp70 antibodies. Figure 2B shows a time- and dose-dependent upregulation of hsp70.
We also investigated whether exposure to Ag NP caused DNA strand breaks in Saos-2 by comet
assay. As demonstrated in Figure 2C, 1 and 2 days of Ag NP treatment induced genotoxic stress as
shown by the formation of comets. Comet assay was also performed on Saos-2 treated 35 days with
Ag NP. Figure 2C (right panel) shows that genotoxicity was completely reversible upon long term
exposure to NP at the concentration of 10 µg/mL, whereas in Saos-2 exposed to 25 µg/mL of Ag NP
genotoxicity was only partially reversible.
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Figure 2. Saos-2 adapt to long term exposure to Ag NP. (A) Saos-2 cells were treated with Ag NP (5, 
10, and 25 µg/mL). On the day in which the untreated control (-) became confluent, all the cells were 
counted and re-seeded at the same density. Data are expressed as the percentage relative to seven 
days-untreated cells. Data represent the means ± SD of three separate experiments in triplicate (* p < 
0.05, ** p < 0.01); (B) Saos-2 were exposed to Ag NP (10 and 25 µg/mL) for 15 and 22 days. Western 
blot was performed using anti-hsp70 antibodies. GAPDH was used as a control of sample loading. (-
: untreated cells); (C) Saos-2 were treated with Ag NP (10 and 25 µg/mL) for 1, 2, and 35 days. Comet 
assay was performed after staining with ethidium bromide and analyzed with a fluorescence 
microscope. (-: untreated cells). 
2.3. Ag NP Do Not Impair the Differentiation of hMSC 
We extended our studies to hMSC, which possess the potential to differentiate into different cell 
types among which osteoblasts. We investigated the effects of various concentration of Ag NP. As 
demonstrated for Saos-2, Ag NP-induced cytotoxicity is dose dependent (Figure 3A). Similarly to 
Saos-2, the IC50 is around 25 µg/mL. We then analyzed ROS induction after Ag NP treatment and 
observed a statistically significant increase of ROS production only at high NP concentrations (50, 75, 
and 100 µg/mL) (Figure 3B).  
Finally, we studied the effects of Ag NP on the osteogenic differentiation of hMSC. The cells 
were cultured in their culture medium (CM) or in a medium containing an osteogenic cocktail (OM) 
in the presence of 10 and 25 µg/mL of Ag NP. Alizarin Red S staining shows a significant increase of 
calcium deposits in the cells cultured in OM independently from the treatment with Ag NP (Figure 
3C), thus indicating that Ag NP do not interfere with the response of the cells to the osteogenic 
cocktail.  
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Figure 2. Saos-2 adapt to long term exposure to Ag NP. (A) Saos-2 cells wer tr ated with Ag NP
(5, 10, and 25 µg/mL). On the day in which the untreated control (-) b ame confluent, all the c lls
were cou ted and r -seeded at the same density. Data are expressed as the percent ge relative to
seven days-untr ated cells. Data represent the means ± SD of three s parate experiments in triplicate
(* p < 0.05, ** p < 0.01); (B) Saos-2 wer exposed to Ag NP (10 and 25 µg/mL) for 15 and 22 days.
Western blot was performed using anti-hsp70 antibodies. GAPDH w s used as a control f sample
loading. (-: untreated cells); (C) Saos-2 were treated with Ag NP (10 and 25 µg/mL) for 1, 2, nd 35 days.
Comet as ay was p rformed after staining with ethidium bromide and nalyzed with a fluorescence
icroscope. (-: untreated ce ls).
2.3. Ag NP Do Not I pair the ifferentiation of h
extended our studies to hMSC, which possess the potential to differentiate into differ nt
cell types among which osteoblasts. W investigated the effects of various concentration of Ag NP.
As demonstrated for Saos-2, Ag NP-induced cytotoxicity is dose dependent (Figure 3A). Similarly to
Saos-2, the I 50 is around 25 µg/mL. We then analyzed ROS induction after Ag P treat ent and
observed a statistically significant increase of R S production only at high NP concentrations (50, 75,
and 100 µ mL) (Figure 3B).
Finall , st ied the effects of Ag NP on the osteogenic differentiation of hMSC. The cells were
cultured in their culture medium (CM) or in a medium containing an osteogenic cocktail (OM) in
the pres nce of 10 and 25 µg/mL of g . Alizarin e st i i s s si ific t i cr se of
calci e sits i t e cells cultured in OM independently from the treatment with Ag NP (Figure 3C),
thus indicating that Ag NP do not interfere with the response of the cells to the oste genic cocktail.
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Figure 3. Ag NP do not impair hMSC differentiation into osteoblasts. (A) hMSC were treated for 5 
days with Ag NP (0.5–100 µg/mL) and MTT assay was performed to assess viability. Data are 
expressed as the percentage of control (-). p value was calculated vs. untreated cells: ** p < 0.01, *** p < 
0.001; (B) hMSC were exposed to Ag NP (5–100 µg/mL) for 24 h and ROS generation was measured. 
Data are shown as the fold increase in ROS levels of NP treated cells compared to control (-). p value 
was calculated vs. untreated cells: * p < 0.05, ** p < 0.01; (C) hMSC were cultured in CM or OM for 15 
days in the presence of Ag NP (10 and 25 µg/mL) and stained with Alizarin Red S. Photographs were 
taken at 10× magnification. After acid extraction, the absorbance was measured at 562 nm. Data are 
represented as the means ± SD of three separate experiments in triplicate: ** p < 0.01, *** p < 0.001. (-: 
untreated cells). 
3. Discussion 
Because (i) postoperative infections of orthopedic implants lead to the failure of fixation and are 
associated with high morbidity, and (ii) antibiotic resistant bacteria are rapidly emerging, Ag NP 
might represent a good candidate for coating these devices, thereby circumventing bacterial 
colonization [24]. However, the use of Ag NP is debated because of their toxicity in vivo and in many 
cell types in vitro [6–11], even though in several cases the underlying mechanisms have not been 
elucidated. Initially, we focused on human osteoblast-like cells and found a dose dependent toxic 
effect of Ag NP, with an IC50 around 25 µg/mL. Previous studies on human fetal osteoblasts have 
demonstrated an impairment of cell viability with 30–60 µg/mL Ag NP after 24 and 48 h because of 
the increase of iNOS [14]. Differently from [14], we did not detect any significant modulation of nitric 
oxide synthesis after exposure to Ag NP from 0.5 to 100 µg/mL for 24 and 48 h (data not shown). It 
should be noted that discrepancies could be attributed, at least in part, to the different treatment 
protocols used, to NP composition, and to their different size. Ag NP used in [14] are 18–20 nm in 
size, while ours are around 30 nm, and it is well accepted that an inverse correlation exists between 
cytotoxicity and NP size [25].  
In Saos-2, after the addition of Ag NP, we detected an increase of ROS and oxidative damage to 
the DNA. These results are in agreement with a large part of the literature indicating ROS as 
important mediators of Ag NP cyto- and geno-toxicity [7]. Indeed, Ag NP impair the mitochondrial 
respiratory chain with consequent accumulation of ROS and reduced synthesis of ATP [7]. However, 
it is noteworthy that 5 µg/mL Ag NP are cytotoxic without inducing ROS accumulation. Therefore, 
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Figure 3. Ag NP do not impair hMSC differentiation into osteoblasts. (A) hMSC were treated for 5 days
with Ag NP (0.5–100 µg/mL) and MTT assay was performed to assess viability. Data are expressed
as the percentage of co trol (-). p value was calculated vs. untreated cells: ** p < 0.01, *** p < 0.001;
(B) hMSC were exposed to Ag NP (5–100 µg/mL) for 24 h and ROS generation was measured. Data are
shown as t e fold increase i ROS levels of NP treated cells compared to contr l (-). p value was
calculated vs. untreated cells: * p < 0.05, ** p < 0.01; (C) hMSC were cultured in CM or OM for 15 days
in the pres nc of Ag NP (10 and 25 µg/mL) and stained with Alizarin Red S. Photographs were
taken at 10× a ificati . ft ci extracti , the absorbance as easured at 562 nm. Data are
represented as the eans of three separate experiments in triplicate: ** p < .01, *** p < 0.001.
(-: untreated cells).
3. Discussion
Because (i) postoperative infections of orthopedic implants lead to the failure of fixation and are
associated with high morbidity, and (ii) antibiotic resistant bacteria are rapidly emerging, Ag NP might
represent a good candidate for coating these devices, thereby circumventing bacterial colonization [24].
However, the use of Ag NP is debated because of their toxicity in vivo and in many cell types
in vitro [6–11], even though in several cases the underlying mechanisms have not been elucidated.
Initially, we focused on human osteoblast-like cells and found a dose dependent toxic effect of Ag
NP, with an IC50 around 25 µg/mL. Previous studies on human fetal osteoblasts have demonstrated
an i pairment of cell viability with 30–60 µg/mL Ag NP after 24 and 48 h because of the increase of
iNOS [14]. Differently from [14], we did not detect any significant modulation of nitric oxide synthesis
after exposure to Ag NP from 0.5 to 100 µg/mL for 24 and 48 h (data not shown). It should be noted
that discrepancies could be attributed, at least in part, to the different treatment protocols used, to NP
composition, and to their different size. Ag NP used in [14] are 18–20 nm in size, while ours are around
30 nm, and it is well accepted that an inverse correlation exists between cytotoxicity and NP size [25].
In Saos-2, after the addition of Ag NP, we detected an increase of ROS and oxidative damage
to the DNA. These results are in agreement with a large part of the literature indicating ROS as
important mediators of Ag NP cyto- and geno-toxicity [7]. Indeed, Ag NP impair the mitochondrial
respiratory chain with consequent accumulation of ROS and reduced synthesis of ATP [7]. However,
it is noteworthy that 5 µg/mL Ag NP are cytotoxic without inducing ROS accumulation. Therefore,
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the accumulation of ROS might contribute to cytotoxicity only at high concentrations of Ag NP and
other undisclosed mechanisms are involved in mediating the effects of Ag NP in Saos-2.
It is relevant to underscore that, over time, Saos-2 adapt to the presence of Ag NP through
the activation of a stress response. We found that Saos-2 cultured in the presence of sublethal
concentrations of Ag NP upregulate hsp70 and this parallels the decrease of oxidative damage to
DNA and the gradual recovery of cell proliferation. Indeed, in addition to its primary action as a
chaperone, hsp70 interacts with crucial regulators of many signal transduction pathways controlling
cell proliferation, differentiation, and death [26]. High levels of hsp70 protect against apoptosis by
inhibiting caspase-dependent and independent pathways. Moreover, hsp70 is important in the control
of cell cycling and growth and, accordingly, some oncogenes upregulate hsp70 [26]. We conclude that
Saos-2 adapt and resist to Ag NP because of the upregulation of hsp70.
hMSC show a response to Ag NP that is very similar to that of Saos-2. The IC50 is around 25 µg/mL
and the overproduction of ROS is observed with 50 µg/mL and over. Again, we argue for alternative
pathways responsible for cytotoxicity. Interestingly, Ag NP do not influence the differentiation of
hMSC towards osteoblasts. Our results are in accordance with a previous report [16]. The different
size of nanoparticles used as well as the different experimental protocol might explain the different
results obtained by Sengstock et al. [17], who showed an attenuation of adipogenic and osteogenic
differentiation in hMSC treated with 80 nm size Ag NP.
Both hMSC and Saos-2 seem to be rather resistant to the toxic effect of Ag NP if compared with
cell types we previously used. Bladder carcinoma T24 and microvascular endothelial cells showed an
IC50 around 7.5 and 2.5 µg/mL Ag NP, respectively [8,9]. In the light of a use for orthopedic implants,
it should be recalled that the concentrations of Ag NP required to obtain bactericidal effects are lower
than those which are toxic for bone cells [27,28]. Additionally, it is likely that the incorporation of Ag
NP in biomaterials might further decrease cytotoxicity on eukaryotic cells.
Another challenging issue that has recently emerged is the demonstration of a gender-dependent
sensitivity to NP of different sizes. Lee and colleagues [29] reported a longer persistence of Ag NP in
the blood of female Sprague-Dawley rats after oral administration of high concentrations of 25 nm Ag
NP. On the contrary, a longer persistence of 10 nm Ag NP was reported in male rats. This result might
be hormone-dependent. Cultured cells represent a simple and useful preclinical model to decipher the
mechanisms of Ag NP toxicity, but cannot provide any hint about gender differences.
In conclusion, we suggest that Ag NP might be used as antimicrobial materials, without
compromising the behavior of bone-forming cells.
4. Materials and Methods
4.1. Reagents
Spherical Ag NP with an average size of 35 nm (#0476JY, NanoAmor, Houston, TX, USA) were
previously used [8]. They have surface area of 30–50 m2/g. Stock solution of these NP was suspended
in Dulbecco’s Modified Eagle’s Medium (DMEM) at a concentration of 1080 mg/mL. We have assessed
that NP stock solution can be maintained at 4 ◦C for one month without altering NP properties
(not shown). This solution was sonicated many times just before its dilution in culture medium.
4.2. Cell Culture
Saos-2 (American Type Culture Collection) were cultured in DMEM with 10% fetal bovine serum
and 2 mM glutamine at 37 ◦C and 5% CO2. hMSC were isolated from adult human bone marrow [23]
according to IRCCS Policlinico institutional guidelines and characterized by flow cytometry. These cells
were cultured at 37 ◦C and 5% CO2 in DMEM with 1000 mg/L glucose, 10% FBS, and 2 mM glutamine
(culture medium, CM). All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
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4.3. Cell Viability Assay
To test the effects of Ag NP, we used the MTT assay. Saos-2 and hMSC were seeded at
6500/cm2 in 96 well/plates and 24 h later exposed to Ag NP. After five days of treatment,
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide was added (MTT, 0.5 mg/mL)
(Sigma-Aldrich, St. Louis, MO, USA) as described [9]. Formazan crystals were dissolved in DMSO and
absorbance was measured at 550 nm.
In long-term experiments, Saos-2 (6500/cm2) were seeded in 24 well/plates 24 h prior to treatment
with Ag NP. When the untreated cells were confluent, the cells were trypsinized, counted using an
automated counter, and seeded (6500/cm2) in a new 24-well plate in the presence of the correspondent
concentrations of Ag NP. Data represent the mean ± standard deviation of three separate experiments
in triplicate.
4.4. Flow Cytometric Analysis of Cell Death
The effect of Ag NP on cell death was investigated by Annexin V-FITC and propidium iodide (PI)
staining as described [8]. Briefly, Saos-2 cells were harvested, extensively washed, centrifuged at
1200 rpm for 5 min and stained for 30 min with 5 mL of Annexin V-FITC and 5 mL PI according to
the manufacturer’s protocol (Immunostep, Salamanca, Spain). The samples were then evaluated by
cytofluorimetry using the FACScalibur (BD Biosciences, Singapore) at 10,000 events for each sample [8].
4.5. Reactive Oxygen Species Production
The levels of intracellular ROS were measured using 2′-7′-dichlorofluorescein diacetate (DCFH)
as previously described [8,9]. Cells seeded in black bottomed 96-well plates were exposed to different
concentrations of Ag NP. 24 h later, 20 µM DCFH solution were added to the culture media. The rate
of ROS production was monitored following the emission at 529 nm of the DCFH dye with Promega
Glomax Multi Detection System [8,9]. Three independent experiments in triplicate were performed
and the results are shown as the fold increase in ROS levels of Ag NP-treated cells vs. the control ±
standard deviation.
4.6. Comet Assay (Single Cell Electrophoresis)
Saos-2 were seeded in 24-well plates 24 h prior to exposure to 10 and 25 ug/mL of Ag NP.
Untreated cells were the controls. At the end of the experiment, cells were trypsinized, mixed with
low melting-point agarose, and spread on agarose pretreated slides as described [9]. Slides were dried
and immersed in lysis solution [9] at 4 ◦C for 60 min. Electrophoresis was performed for 30 min at
300 mA in ice cold running buffer [9]. Then, slides were rinsed in Tris-HCl pH 7.5, fixed in ice-cold
methanol for 3 min, dried at room temperature, stained with ethidium bromide, and analyzed using a
fluorescence microscope.
4.7. Western Blot Analysis
Lysates (100 µg/lane) were run on a 10% SDS-polyacrylamide gel, transferred to nitrocellulose
sheets for 16 h at 150 mA, and probed with antibodies against hsp70 or GAPDH (Santa Cruz
Biotechnology, Dallas, TX, USA). Secondary antibodies were labelled with horseradish peroxidase
(GE Healthcare, Little Chalfont, UK). Immunoreactive proteins were visualized by the SuperSignal
chemiluminescence kit (Pierce, Thermo Fischer scientific, Monza, Italy). The experiment was repeated
three times and one representative blot is shown.
4.8. In Vitro Osteogenic Differentiation of hMSC
Confluent hMSC were cultured in their culture medium (CM) or in a medium containing an
osteogenic cocktail (OM) in the presence of 10 and 25 µg/mL of Ag NP. The OM contains 2 × 10−8 M
1α,25-Dihydroxyvitamin D3, 10 mM β-glycerolphosphate and 0.05 mM ascorbic acid (Sigma-Aldrich,
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St. Louis, MO, USA). To detect calcium in the extracellular matrix, hMSC were rinsed with phosphate
buffered saline, fixed (70% ethanol, 1 h), and stained with 2% Alizarin Red S staining (pH 4.2,
Sigma-Aldrich, St. Louis, MO, USA) for 10 min [19]. Quantification of calcium deposition was
performed after solubilization in 10% cetylpyridinium chloride (Sigma-Aldrich, St. Louis, MO, USA)
and resuspended in 10 mM sodium phosphate (pH 7.0). The absorbance was measured at 562 nm.
4.9. Statistical Analysis
Student’s t-test was used for calculating Statistical significance. * p < 0.05, ** p < 0.01, *** p < 0.001.
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